Primaxin

Country: New Zealand

Language: English

Source: Medsafe (Medicines Safety Authority)

Active ingredient:

Cilastatin sodium 571mg equivalent to to 500 mg cilastatin acid. Includes 4.6% overage.; Imipenem monohydrate 560mg equivalent to to 500 mg imipenem. Includes 4.6% overage.

Available from:

Merck Sharp & Dohme (New Zealand) Limited

INN (International Name):

Cilastatin sodium 571 mg (Equiv. to 500 mg cilastatin acid. Includes 4.6% overage.)

Pharmaceutical form:

Powder for injection

Composition:

Active: Cilastatin sodium 571mg equivalent to to 500 mg cilastatin acid. Includes 4.6% overage. Imipenem monohydrate 560mg equivalent to to 500 mg imipenem. Includes 4.6% overage. Excipient: Sodium bicarbonate

Units in package:

Ampoule, glass, 5x13ml (Monovial), 5 dose units

Class:

Prescription

Prescription type:

Prescription

Manufactured by:

Merck Sharp & Dohme Corp

Product summary:

Package - Contents - Shelf Life: Ampoule, glass, 5x13ml (Monovial) - 5 dose units - 24 months from date of manufacture stored at or below 25°C 4 hours reconstituted stored at or below 25°C 24 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze)

Authorization date:

1996-03-20